D P Andersson1, E Arner1,2, D E Hogling1, M Rydén1, P Arner1. 1. Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. 2. RIKEN Center for Life Science Technologies, Molecular Network Control Genomics Unit, Yokohama, Kanaga-wa, Japan.
Abstract
BACKGROUND/ OBJECTIVE: Differences in subcutaneous abdominal adipose tissue (SAT) fat cell size and number (cellularity) are linked to insulin resistance. Men are generally more insulin resistant than women but it is unknown whether there is a gender dimorphism in SAT cellularity. The objective was to determine SAT cellularity and its relationship to insulin sensitivity in men and women. METHODS: In a cohort study performed at an outpatient academic clinic in Sweden, 798 women and 306 men were included. Estimated SAT mass (ESAT) was derived from measures of dual-energy X-ray absorptiometry and a formula. SAT biopsies were obtained to measure mean fat cell size; SAT adipocyte number was obtained by dividing ESAT with mean fat cell weight. Fat cell size was also compared with level of insulin sensitivity in vivo. RESULTS: Over the entire range of body mass index (BMI) both fat cell size and number correlated positively with ESAT in either sex. On average, fat cell size was larger in men than in women, which was driven by significantly larger fat cells in non-obese men compared with non-obese women; no gender effect on fat cell size was seen in obese subjects. For all subjects fat cell number was larger in women than men, which was driven by a gender effect among non-obese individuals (P<0.0001). The relationship between fat cell size and insulin resistance was significant in both genders (P<0.0001) but steeper in men than in women (F=19, P<0.0001). CONCLUSIONS: Although both fat cell size and number determine SAT mass, adipocyte number contributes more and size less in women than in men and this is most evident in non-obese subjects. Over the entire BMI range, fat cell size contributes stronger to insulin resistance in men.
BACKGROUND/ OBJECTIVE: Differences in subcutaneous abdominal adipose tissue (SAT) fat cell size and number (cellularity) are linked to insulin resistance. Men are generally more insulin resistant than women but it is unknown whether there is a gender dimorphism in SAT cellularity. The objective was to determine SAT cellularity and its relationship to insulin sensitivity in men and women. METHODS: In a cohort study performed at an outpatient academic clinic in Sweden, 798 women and 306 men were included. Estimated SAT mass (ESAT) was derived from measures of dual-energy X-ray absorptiometry and a formula. SAT biopsies were obtained to measure mean fat cell size; SAT adipocyte number was obtained by dividing ESAT with mean fat cell weight. Fat cell size was also compared with level of insulin sensitivity in vivo. RESULTS: Over the entire range of body mass index (BMI) both fat cell size and number correlated positively with ESAT in either sex. On average, fat cell size was larger in men than in women, which was driven by significantly larger fat cells in non-obesemen compared with non-obesewomen; no gender effect on fat cell size was seen in obese subjects. For all subjects fat cell number was larger in women than men, which was driven by a gender effect among non-obese individuals (P<0.0001). The relationship between fat cell size and insulin resistance was significant in both genders (P<0.0001) but steeper in men than in women (F=19, P<0.0001). CONCLUSIONS: Although both fat cell size and number determine SAT mass, adipocyte number contributes more and size less in women than in men and this is most evident in non-obese subjects. Over the entire BMI range, fat cell size contributes stronger to insulin resistance in men.
Authors: Yourka D Tchoukalova; Christina Koutsari; Susanne B Votruba; Tamara Tchkonia; Nino Giorgadze; Thomas Thomou; James L Kirkland; Michael D Jensen Journal: Obesity (Silver Spring) Date: 2010-03-18 Impact factor: 5.002
Authors: T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman Journal: Diabetologia Date: 2007-06-05 Impact factor: 10.122
Authors: Sanjiv Kaul; Megan P Rothney; Dawn M Peters; Wynn K Wacker; Cynthia E Davis; Michael D Shapiro; David L Ergun Journal: Obesity (Silver Spring) Date: 2012-01-26 Impact factor: 5.002
Authors: Erik Arner; Pål O Westermark; Kirsty L Spalding; Tom Britton; Mikael Rydén; Jonas Frisén; Samuel Bernard; Peter Arner Journal: Diabetes Date: 2009-10-21 Impact factor: 9.461
Authors: Meron Teklu; Wunan Zhou; Promita Kapoor; Nidhi Patel; Martin P Playford; Alexander V Sorokin; Amit K Dey; Heather L Teague; Grigory A Manyak; Justin A Rodante; Andrew Keel; Marcus Y Chen; David A Bluemke; Amit V Khera; Nehal N Mehta Journal: Am J Prev Cardiol Date: 2021-08-22
Authors: Michaela Keuper; Lucia Berti; Bernhard Raedle; Stephan Sachs; Anja Böhm; Louise Fritsche; Andreas Fritsche; Hans-Ulrich Häring; Martin Hrabě de Angelis; Martin Jastroch; Susanna M Hofmann; Harald Staiger Journal: Mol Metab Date: 2018-11-26 Impact factor: 7.422
Authors: Carl Herdenberg; Pascal M Mutie; Ola Billing; Ahmad Abdullah; Rona J Strawbridge; Ingrid Dahlman; Simon Tuck; Camilla Holmlund; Peter Arner; Roger Henriksson; Paul W Franks; Håkan Hedman Journal: Commun Biol Date: 2021-01-19
Authors: Ana Elena Espinosa De Ycaza; Esben Søndergaard; Maria Morgan-Bathke; Barbara Gisella Carranza Leon; Kelli A Lytle; Paola Ramos; James L Kirkland; Tamar Tchkonia; Michael D Jensen Journal: Obesity (Silver Spring) Date: 2021-06-10 Impact factor: 9.298